Journal List > Korean J Health Promot > v.19(4) > 1141851

Jung: Association between High-Density Lipoprotein Cholesterol and Vitamin D Levels in Adult Men in the Fifth Korea National Health and Nutrition Examination Survey

Abstract

Background

Patients with metabolic syndrome had low high-density lipoprotein cholesterol (HDL-C) levels. Moreover, vitamin D deficiency is also related to metabolic syndrome. This study aimed to investigate the association between vitamin D and HDL-C levels.

Methods

To determine the association between HDL-C and vitamin D levels, 5,537 males who had no missing values were systematically selected from the fifth Korea National Health and Nutrition Examination Survey. Then, the association was investigated by a multivariable logistic regression analysis after adjusting for the effects of confounding factors on vitamin D and HDL-C levels, such as age, body mass index (BMI), sociodemographic factors, and lifestyle factors.

Results

In Korean men aged ≥20 years, the mean vitamin D and HDL-C levels were 18.3±0.2 ng/mL and 46.8±0.2 mg/dL, respectively. Moreover, the prevalence of low HDL-C levels was 29.2±0.8%. After adjusting for age, BMI, sociodemographic factors, and lifestyle factors, the risk of low HDL-C levels in the lowest quartile of vitamin D level was 1.296 (95% confidence interval [CI], 1.035–1.623) times higher and that in the second quartile of vitamin D level was 1.354 (95% CI, 1.086–1.690) times higher than that in the third quartile of vitamin D level (P<0.05).

Conclusions

The risk of low HDL-C levels is associated with vitamin D level after adjustment for age, BMI, sociodemographic factors, and lifestyle factors.

Figures and Tables

Table 1

General characteristics of study subjects (n=5,537)

kjhp-19-210-i001

Abbreviations: 25(OH)D, 25-hydroxyvitamin D; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; SE, standard error.

aCalculated by complex sample descriptive statistics.

Table 2

Frequency analysis of study subjects (n=5,537)a

kjhp-19-210-i002

Abbreviations: 25(OH)D, 25-hydroxyvitamin D; AUDIT, Alcohol Use Disorders Identification Test; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; SE, standard error.

aCalculated by complex sample frequency analysis.

Table 3

The possible characteristics associated with high-density lipoprotein cholesterol and 25-hydroxyvitamin D levels

kjhp-19-210-i003

Abbreviations: 25(OH)D, 25-hydroxyvitamin D; AUDIT, Alcohol Use Disorders Identification Test; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; N, unweighted frequency; SE, standard error.

aCalculated by complex sample descriptive statistics.

bCalculated by complex sample general linear model.

Table 4

Association of low high-density lipoprotein cholesterol and 25-hydroxyvitamin D levels in men aged ≥20 years in KNHANES V

kjhp-19-210-i004

Values are presented as odds ratio (95% confidence interval).

Abbreviations: 25(OH)D, 25-hydroxyvitamin D; AUDIT, Alcohol Use Disorders Identification Test; CI, confidence interval; KNHANES, Korea National Health and Nutrition Examination Survey; OR, odds ratio.

aAdjusted by BMI and age.

bAdjusted by factors in model 1 and sociodemographic factors; e.g., region, residence, household income, education, and occupation.

cAdjusted by factors in model 2 and life style factors; e.g., physical activity, smoking status, and alcohol use.

dCalculated by complex sample logistic regression analysis.

References

1. Natarajan P, Ray KK, Cannon CP. High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol. 2010; 55(13):1283–1299.
2. Riggs KA, Rohatgi A. HDL and reverse cholesterol transport biomarkers. Methodist Debakey Cardiovasc J. 2019; 15(1):39–46.
crossref
3. Bardagjy AS, Steinberg FM. Relationship between HDL functional characteristics and cardiovascular health and potential impact of dietary patterns: a narrative review. Nutrients. 2019; 11(6):1231.
crossref
4. Brites F, Martin M, Guillas I, Kontush A. Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit. BBA Clin. 2017; 8:66–77.
crossref
5. Bikle DD. Extraskeletal actions of vitamin D. Ann N Y Acad Sci. 2016; 1376(1):29–52.
crossref
6. Marino R, Misra M. Extra-Skeletal effects of vitamin D. Nutrients. 2019; 11(7):1460.
crossref
7. Oberoi D, Mehrotra V, Rawat A. “Vitamin D” as a profile marker for cardiovascular diseases. Ann Card Anaesth. 2019; 22(1):47–50.
crossref
8. Sun X, Cao ZB, Tanisawa K, Ito T, Oshima S, Ishimi Y, et al. Associations between the serum 25(OH)D concentration and lipid profiles in Japanese men. J Atheroscler Thromb. 2015; 22(4):355–362.
crossref
9. Chaudhuri JR, Mridula KR, Anamika A, Boddu DB, Misra PK, Lingaiah A, et al. Deficiency of 25-hydroxyvitamin d and dyslipidemia in Indian subjects. J Lipids. 2013; 2013:623420.
crossref
10. Park JE, Pichiah PBT, Cha YS. Vitamin D and metabolic diseases: growing roles of vitamin D. J Obes Metab Syndr. 2018; 27(4):223–232.
crossref
11. Sarmiento-Rubiano LA, Angarita Ruidiaz JA, Suarez Dávila HF, Suarez Rodríguez A, Rebolledo-Cobos RC, Becerra JE. Relationship between serum vitamin D levels and HDL cholesterol in postmenopausal women from Colombian caribbean. J Nutr Metab. 2018; 2018:9638317.
crossref
12. Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation. 2012; 126(3):270–277.
13. Ponda MP, Liang Y, Kim J, Hutt R, Dowd K, Gilleaudeau P, et al. A randomized clinical trial in vitamin D-deficient adults comparing replenishment with oral vitamin D3 with narrow-band UV type B light: effects on cholesterol and the transcriptional profiles of skin and blood. Am J Clin Nutr. 2017; 105(5):1230–1238.
14. Wieder-Huszla S, Jurczak A, Szkup M, Barczak K, Dołęgowska B, Schneider-Matyka D, et al. Relationships between vitamin D3 and metabolic syndrome. Int J Environ Res Public Health. 2019; 16(2):175.
15. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2011. Accessed Feb 21, 2019. Available from: https://knhanes.cdc.go.kr/knhanes/sub03/sub03_02_02.do.
16. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2011: Korea National Health and Nutrition Examination Survey (KNHANES V-2) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2012. Accessed Feb 21, 2019. Available from: https://knhanes.cdc.go.kr/knhanes/sub03/sub03_02_02.do.
17. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2012: Korea National Health and Nutrition Examination Survey (KNHANES V-3) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2013. Accessed Feb 21, 2019. Available from: https://knhanes.cdc.go.kr/knhanes/sub03/sub03_02_02.do.
18. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43(1):69–77.
crossref
19. Yun YM, Song J, Ji M, Kim JH, Kim Y, Park T, et al. Calibration of high-density lipoprotein cholesterol values from the Korea National Health and Nutrition Examination Survey Data, 2008 to 2015. Ann Lab Med. 2017; 37(1):1–8.
crossref
20. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16):1640–1645.
21. Bahor TF, Higgins-Biddle JC, Saunders JB, Monterio MG. World Health Organization. AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care. 2nd ed. Geneva: World Health Organization;2001.
22. Kim J, Chu SK, Kim K, Moon JR. Alcohol use behaviors and risk of metabolic syndrome in South Korean middle-aged men. BMC Public Health. 2011; 11:489.
crossref
23. Wang T, Sun H, Ge H, Liu X, Yu F, Han H, et al. Association between vitamin D and risk of cardiovascular disease in Chinese rural population. PLoS One. 2019; 14(5):e0217311.
crossref
24. Wang H, Peng DQ. New insights into the mechanism of low high-density lipoprotein cholesterol in obesity. Lipids Health Dis. 2011; 10:176.
crossref
25. Cho KH, Park HJ, Kim SJ, Kim JR. Decrease in HDL-C is associated with age and household income in adults from the Korean National Health and Nutrition Examination Survey 2017: correlation analysis of low HDL-C and poverty. Int J Environ Res Public Health. 2019; 16(18):3329.
crossref
26. Králová Lesná I, Suchánek P, Stávek P, Poledne R. May alcohol-induced increase of HDL be considered as atheroprotective? Physiol Res. 2010; 59(3):407–413.
27. Jung IK. Association of Smoking status and high density lipoprotein-cholesterol in males in the fifth Korea National Health and Nutrition Examination Survey. Korean J Health Promot. 2017; 17(4):289–297.
crossref
28. Forey BA, Fry JS, Lee PN, Thornton AJ, Coombs KJ. The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes. Biomark Res. 2013; 1(1):26.
crossref
29. Kardassis D, Gafencu A, Zannis VI, Davalos A. Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslational. Handb Exp Pharmacol. 2015; 224:113–179.
crossref
30. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989; 79(1):8–15.
crossref
TOOLS
ORCID iDs

In Kyung Jung
https://orcid.org/0000-0002-6197-2255

Similar articles